Background. Immunization prepares the body for a reencounter with the microbe. Information on the targeting of immune effector cells during secondary immune response-that is, lymphocyte homing-is scarce. In the present study, the homing potentials of lymphocytes are examined after antigen reencounter at mucosal versus nonmucosal sites.
Since the ultimate purpose of immunization is to prepare the body for a possible encounter with the microbe, it is amazing how small a fraction of research has been focused on characterization of B cells in secondary immune responses. Our understanding of the basic mechanisms of lymphocyte migration in the body has advanced considerably in recent years, and the homing event has been recognized as a sophisticated multistep process. It has become evident that, whereas naive cells are able to migrate equally to all secondary lymphoid tissues, activated lymphocytes gain tissue-selective homing abilities and can, in addition, invade tertiary lymphoid tissues [1] [2] [3] [4] [5] [6] [7] [8] . This tissue-selective homing enables effective targeting of immune responses to sites where the antigen is most probably encountered. Tissue-selective trafficking of memory and effector lymphocytes is mediated by unique combinations of adhesion molecules and chemokines. The discovery of several related chemokines at the epithelial surfaces suggests an important role for epithelial cells in the localization of lymphocytes [3] . An interaction between lymphocyte surface homing receptors (HRs) and their counterparts, addressins, expressed by endothelial cells of target tissues, is known to be a central event in the tissue-selective homing of lymphocytes [1, 2, [5] [6] [7] [8] . The best-characterized HR-addressin pairs include the gut HR (a 4 b 7 ) and MAdCAM-1, expressed by endothelial cells of the intestinal lamina propria [9] [10] [11] ; the peripheral lymph node (PLN) HR (L-selectin) and the PLN addressin (PNAd) [12] [13] [14] ; and the skin HR (cutaneous lymphocyte antigen [CLA] ) and E-selectin, in cutaneous tissues [15, 16] .
Studies of primary immunization have revealed that tissue selectivity in the homing of activated human lymphocytes depends on the site of antigen encounter [17] [18] [19] [20] [21] [22] . Mucosal antigen encounter in the intestine elicits activated lymphocytes, all of which express the gut HR, a 4 b 7 , whereas parenteral immunization with the same antigen results in cells with the PLN HR, L-selectin, as the most frequently expressed HR [17] . This suggests that lymphocytes tend to home back to sites where the initial antigen encounter took place, which is consistent with the current dogma on lymphocyte migration. Research has focused on HR expression on naive lymphocytes, on lymphocytes activated by primary antigen encounter, or on memory lymphocytes. With regard to events taking place after secondary contact with an antigen, information on homing of B effector cells is practically lacking.
The present study was undertaken to investigate homing potentials of lymphocytes activated by secondary antigen encounter, either at the same site at which the initial antigen encounter took place or at a distant site. The results revealed differences in HR expression, suggesting site-dependent unique homing patterns of activated lymphocytes after secondary antigen challenge. These data may prove valuable in the search for the most effective immunization route in humans.
MATERIALS AND METHODS
The expression of HR was studied on circulating specific antibody-secreting cells (ASCs) induced by an oral or a parenteral secondary antigen challenge with Salmonella typhi Ty21a after either oral or parenteral primary immunization. Expression of the HRs a 4 b 7 and L-selectin was examined by combining immunomagnetic cell sorting with the enzyme-linked immunospot (ELISPOT) assay for S. typhi-specific IgA ASCs, IgG ASCs, or IgM ASCs.
Vaccinations and collection of samples. Thirty-six healthy volunteers (15 men and 21 women; aged 18-42 years) participated in this study. None of the vaccine recipients had a history of typhoid fever, and none of them had received a typhoid vaccine previously. Informed consent was received from all participants. Human experimentation guidelines of the US Department of Health and Human Services and those of the authors' institutions were followed in the conduct of clinical research. The study protocol was approved by the Ethics Committees of the National Public Health Institute, the Hospital for Children and Adolescents, the University of Helsinki, the Central Hospital of Central Finland, and the University of Jyväskylä. The research was performed at the National Public Health Institute, Helsinki, and at the Department of Cell Biology, University of Jyväskylä, Jyväskylä, Finland.
The volunteers were divided into 4 groups of 9 individuals.
Each group was given the typhoid vaccine orally or parenterally, as primary immunization, followed by oral or parenteral secondary immunization 3-30 months later, as follows: group 1, oral + oral; group 2, oral + parenteral; group 3, parenteral + oral; and group 4, parenteral + parenteral. The oral vaccine was the live attenuated S. typhi Ty21a vaccine (Vivotif Berna, Swiss Serum and Vaccine Institute), consisting of at least 2 ϫ 10 9 -bacteria/dose. The oral vaccine was administered 9 6 ϫ 10 as 3 doses 2 days apart, in accordance with the manufacturer's instructions. For oral reimmunization, the same protocol was chosen, to optimize the comparisons of HR in the 2 situations. The parenteral Ty21a vaccine was prepared at the Swiss Serum and Vaccine Institute, Bern, according to a previously described protocol [23] . Each volunteer received an intramuscular (im) injection (0.5 mL) of this vaccine in the left arm, with each dose consisting of formalin-killed bacteria. The pri-9 0.5 ϫ 10 mary and the secondary parenteral immunizations were performed similarly. One volunteer in the oral + parenteral group withdrew from the study after ingestion of 1 capsule, because of general malaise.
Samples of heparinized blood were collected from the volunteers 7 days after primary vaccination and 7 days after secondary vaccination. This timing of sampling was based on our previous studies demonstrating that ASCs appear in the blood a few days after immunization, peak around day 7, and disappear within a few weeks [23, 24] .
Isolation of mononuclear cells. The mononuclear cells were isolated from heparinized venous blood by Ficoll-Paque density-gradient centrifugation, as described elsewhere [24] .
Separation of the receptor-negative and -positive cell populations. The separation of the cells into receptor-negative and -positive populations has been described in detail elsewhere [25] . In brief, the cells were incubated in the first stage with the monoclonal antibodies anti-a 4 b 7 (ACT-1) (Millennium Pharmaceuticals) and anti-L-selectin (Leu8) (Becton Dickinson) for 30 min on ice. The cells were then washed twice with 1% fetal calf serum-PBS and incubated with Dynal M-450 magnetic beads coated with sheep anti-mouse IgG (Dynal) for 30 min on ice. The beads with the attached cells were then separated from the suspension by applying a magnet to the outside of the test tubes, and the supernatants with the receptor-negative cells were collected. Next, the beads were washed, the magnetic separation was repeated, and the supernatant was pooled with the initial population of negatively selected cells. The receptorpositive cells attached to the beads were then suspended in medium. Both the receptor-positive and -negative cell populations were immediately analyzed by use of the ELISPOT assay for numbers of vaccine antigen-specific ASCs. The efficiency of the cell separations has been checked in pilot experiments, as described elsewhere [17] .
ELISPOT assay of specific ASCs. The receptor-positive and -negative cell populations were each assayed for specific ASCs by use of the ELISPOT assay; the assay of specific ASCs has been described in detail elsewhere [24] . In brief, 96-well microtiter plates (Maxisorp; Nunc) were coated with a whole-cell preparation of formalin-killed Salmonella strain SL2404 (10 8 bacteria/mL of PBS) sharing the O-9,12 antigen with the vaccine strain [24] . The wells were blocked with 1% bovine serum albumin in PBS. Then, the cells were incubated in the wells for 3 h, and antibodies secreted during this time were detected with alkaline-phosphatase-conjugated swine anti-human IgA, IgM (diluted 1:100; Orion Diagnostica), or goat anti-human IgG (diluted 1:500; Sigma) antisera, followed by application of substrate (5-bromo-4-chloro-3-indolylphosphate; Sigma) in melted agarose. For each immunoglobulin isotype-surface marker combination, -cells were screened. Specific ASCs 6 6 0.8 ϫ 10 4.8 ϫ 10 were enumerated by counting the spots in the wells in a light microscope. A "responder" was defined as a volunteer with 12 specific ASCs/10 6 peripheral blood mononuclear cells (PBMCs). Statistics. To obtain reliable statistics for the proportions of cells expressing a given marker, we set an exclusion limit of 20 ASCs that needed to be identified among the cells studied. The proportions of the receptor-positive ASCs were calculated as follows: percentage of receptor-positive cells among ASCs p (100 ϫ the number of ASCs in the receptor-positive population)/(the sum of the number of ASCs in the receptor-positive and receptor-negative populations). Percentages of cells expressing the different receptors were determined as arithmetic means (‫ע‬SDs) of the proportions of ASCs expressing the given cell-surface marker. Statistical comparisons were performed using Student's t test.
RESULTS
To provide information on lymphocyte homing after a reencounter with the microbe, we investigated the homing potentials of activated antigen-specific lymphocytes after secondary antigen contact. The expression of HRs was studied in 4 vaccination groups, the members of which received the S. typhi Ty21a vaccine (1) orally + orally, (2) orally + parenterally, (3) parenterally + orally, or (4) parenterally + parenterally.
General Characteristics of the ASC Responses
Of the 35 volunteers (1 of the original 36 volunteers withdrew; see above), 33 provided data for this study, since 1 volunteer after parenteral primary immunization and 1 volunteer after oral secondary immunization were excluded as nonresponders. The volunteer not responding after primary immunization was not reimmunized.
After oral primary vaccination, the responses were, in most cases, dominated by IgA (data not shown), which is consistent with the results of our previous studies [23, 24] . After parenteral primary immunization, in the majority of the cases, IgM dominated the response (data not shown). After secondary immunizations, no clear dominating immunoglobulin class was found. In the orally primed group, the geometric means ‫ע‬ of the peak numbers of ASCs (IgA + ; ) of the same volunteers. Even 57.4 ‫ע‬ 25.9 n p 17 if the magnitude of the ASC response did not increase from primary to secondary immunization, qualitative changes in the secondary immune response indicate the existence of memory, as the results described below show. Lack of increase in the magnitude of the secondary immune response could be due to the fact that our assay only measured the response to a polysaccharide antigen present on the vaccine strain. Another probable contributing factor is the time interval between the 2 immunizations, as shown in our previous studies [26] [27] [28] .
Expression of HR on ASCs
After primary vaccination with Ty21a, the exclusion limit of 20 detected ASCs was exceeded in 17 of 17 orally and 14 of 18 parenterally immunized volunteers. After secondary immunization, the limit was exceeded in 15 of 17 orally and 15 of 16 parenterally immunized volunteers. The HR-expression results presented below are based on those volunteers who exceeded this limit. In some of these volunteers, not all receptor analyses could meet this criterion, and the results are shown for only those analyses that did.
Expression of HR after primary immunization. Oral primary immunization elicited circulating ASCs, 97% of which were a 4 b 7 positive (a 4 b 7 + ) and 39% of which were L-selectin positive (L-selectin + ) (figure 1A), consistent with a preferential homing of these cells back to the intestine. In contrast, of the ASCs elicited by parenteral primary immunization, 49% were a 4 b 7 + and 80% were L-selectin + ( figure 1A) , suggesting a preferential homing to the systemic immune system. These data are consistent with those of our previous studies of primary immunization [17, 18] and with the current dogma of preferential lymphocyte homing to the site of antigen encounter.
Expression of HR after oral secondary immunization. After oral reimmunization, the proportion of a 4 b 7 + cells among ASCs was high in the orally and, interestingly, in the parenterally primed group ( and , respectively) (fig-92% ‫ע‬ 15% 88% ‫ע‬ 19% ure 1B). Indeed, when compared with primary immunization, oral reimmunization elicited a 4 b 7 + cells significantly more frequently than did parenteral primary immunization of the same volunteers ( ) ( figure 1A) . The proportion of a 4 b 7 + cells P ! .05 among ASCs induced by oral reimmunization, in contrast, was similar to that after oral primary immunization of the same volunteers ( figure 1A ).
In addition, the proportion of L-selectin + ASCs after oral reimmunization was high in both the orally and the parenterally primed groups ( and , respectively) (figure 1B). 88% ‫ע‬ 19% 87% ‫ע‬ 17% Remarkably, these proportions of L-selectin + cells after oral reimmunization were significantly higher than those after priming via the same route ( ); in contrast, they were similar to those P ! .001 after parenteral priming of the same volunteers ( figure 1A ).
In conclusion, high proportions of both a 4 b 7 + ASCs and Lselectin + ASCs were found after oral secondary immunization, regardless of the site of priming. These data reveal an appearance of a remarkable a 4 b 7 + , L-selectin + population. It is noteworthy that this HR pattern did not resemble that in of any of the previous immunization protocols.
Expression of HR after parenteral secondary immunization. The proportion of a 4 b 7 + ASCs after parenteral reimmunization was similar in the orally and the parenterally primed groups ( and , respectively) ( figure 1C ). Com-37% ‫ע‬ 19% 52% ‫ע‬ 18% pared with the results of primary immunization, these proportions of a 4 b 7 + cells were significantly lower than those after oral priming ( ) but were similar to those after parenteral P ! .001 priming of the same volunteers ( figure 1A) .
The frequency of L-selectin + cells among ASCs after parenteral reimmunization was likewise similar in the orally and parenterally primed groups ( and , re-83% ‫ע‬ 8% 74% ‫ע‬ 14% spectively) ( figure 1C ). These proportions of L-selectin + cells after parenteral reimmunization were significantly higher than the proportions after oral priming (
) and yet were sim-P ! .001 ilar to those after parenteral priming of the same volunteers ( figure 1A ). In conclusion, it appeared that the HR pattern found after parenteral secondary immunization did not depend on the site of antigen priming but resembled the response to parenteral primary immunization.
Contribution of the various isotypes to the differences found in HR expression. The comparisons between the ASC isotypes after vaccination could not be performed in all cases, because the ASC responses within a given isotype did not always exceed the exclusion limit of 20 detected ASCs. After secondary immunization, no statistically significant differences were observed in a 4 b 7 or L-selectin expression between the different ASC isotypes within the immunization groups (data not shown).
Flow-cytometric analysis of HR expression on B cells. In addition to investigating the expression of a 4 b 7 and L-selectin on effector B cells after primary versus secondary immunization, we wanted to compare the expression of these markers on the respective progenitor cells-that is, on naive and memory B cells. Previous studies have shown that naive and memory B cells display different migratory properties [29] . We performed flowcytometric analysis of peripheral blood CD19 + B cells. The majority of B cells were found to be a 4 b 7 + and L-selectin 
DISCUSSION
Lymphocyte migration in the body forms the basis for the function of the entire immune system. Antigen encounter results in a dissemination of active effector and memory lymphocytes to the 2 compartments of the immune system: sites within the mucosal immune system (e.g., mucosal lamina propria) and sites within the systemic immune system (e.g., PLN, bone marrow, and spleen). Among these disseminating cells, ASCs appearing transiently in the circulation represent the actively functioning part of the B cell population. Although several studies have characterized the expression of HRs on the general population of B cells, some have focused on the tiny but important populations of antigen-specific memory cells or, even more interestingly, on recently activated antigen-specific active effector cells [17, 18, [20] [21] [22] [23] [24] [25] . Previous studies [17, 18, 22] have demonstrated that the site of primary antigen encounter determines the expression of HRs on the activated cell. Data on HR expression after secondary immunization in humans are practically lacking. The only data available on parenteral reimmunization lack the comparison with primary response, yet they show that reimmunization with tetanus toxoid induces a response with high proportions of L-selectin + cells [18, 22] and low proportions of a 4 b 7 + cells [18] . The only study providing information on homing potentials after oral reimmunization examined the expression of CLA, the HR for cutaneous sites [30] . We are not aware of any data published before the present study on the potentials of human lymphocytes to home to mucosal versus nonmucosal sites after reimmunization through the oral route.
In the present study, effector B cells after antigen reencounter were investigated for their potentials to home both to the mucosal compartment (gut HR, a 4 b 7 ) and to the systemic compartment (PLN HR, L-selectin) of the immune system. It was found that, similar to primary antigen encounter, the site of antigen reencounter determines the homing potentials of the specific ASCs induced by reimmunization: whereas parenteral reimmunization induced an ASC response with HR profiles resembling those after parenteral primary immunization, oral reimmunization induced ASCs with a unique HR profile. Interestingly, the route of priming was not reflected in the HR profile of the secondary response through either of the 2 reimmunization routes, yet, after oral reimmunization, evidence of a memory response was clearly revealed by the notable, qualitative changes in the HR profile. In the primary response, practically all ASCs induced by oral immunization exhibit the mucosal HR, a 4 b 7 , but only less than half of them have the systemic HR, L-selectin. After secondary oral antigen encounter, the cells retain a 4 b 7 but become double positive by obtaining L-selectin as well. Our results indicate that primary immunization, whether oral or parenteral, seeds memory cells into the gut. These cells in the gut would be responsible for our finding the unique memory response after oral but not after parenteral reimmunization. We would like to define this phenomenon as "gut-localized memory." Relevant in this context is our previous finding of a 4 b 7 , L-selectin double-positive ASCs in patients with cholera infection, probably representing a secondary antigen contact in a country endemic for cholera, Bangladesh [31] . Importantly, this phenomenon was found on both protein and polysaccharide antigen-specific ASCs, suggesting that gut-localized memory is not dependent on the nature of the antigen.
The high frequency of both a 4 b 7 + and L-selectin + cells after oral reimmunization can be regarded as indicating a high potential to home to both of the 2 compartments of the immune system, the mucosal and the systemic. Interestingly, our recent data on the expression of the cutaneous HR, CLA, show an appearance of CLA + cells after oral reimmunization, whereas primary immunization through the same route was unable to induce CLA + cells [30] . The focusing of immune response to the intestine characteristic of primary immunization thus appears to be replaced by a more generalized immune response in secondary immunization. However, the increase in the proportion of Lselectin + cells may not solely be interpreted as an increased potential to home to peripheral lymph nodes. In addition to facilitating lymphocyte homing to lymph nodes, L-selectin is known to interact in Peyer's patches, but not in lamina propria, with the mucosal addressin ligand of a 4 b 7 , MAdCAM-1. This may, in the present study, suggest an increased potential of the effector cells to home to Peyer's patches, where, in fact, the presence of effector cells, at least in the mouse, has been dem-onstrated [32] . It thus appears that oral reimmunization results in cells with an HR profile that allows homing that significantly differs from that after oral primary immunization.
To our knowledge, the present study is the first to investigate, in humans, the homing of lymphocytes to mucosal versus nonmucosal sites after secondary immunization, especially through the oral route. The site of secondary antigen contact was found to determine the homing profile of the cells. A unique homing potential of cells was found after intestinal antigen reencounter, indicating an increased potential of these cells to home both to the mucosal and the systemic compartment of the immune system, and, possibly, an increased potential to recirculate to Peyer's patches. It appears that, regardless of the route of priming, the oral route of reimmunization targets the immune response more broadly than does the parenteral route and, simultaneously, strengthens the intestinal immune response. These results allow us to consider the targeting of the humoral immune response in the human body by choosing the most accurate route of antigen administration on the basis of knowledge of the homing potentials of the induced final effector cells of humoral immunity.
